title: Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinese patients with and without hypertension.
abstract: BACKGROUND
  The interleukin-6 (IL-6) gene promoter G-174C polymorphism has been associated with insulin resistance, hypertension, and coronary artery disease; however, its relationship with plasma PAI-1 level has not yet been studied.
  
  
  METHODS
  The G-174C genotypes and plasma PAI-1 antigen and activity were determined in 424 Chinese subjects, 207 with hypertension and 217 without, to study the possible effects of IL-6 genotypes on the regulation of PAI-1 and blood pressure.
  
  
  RESULTS
  Hypertensive patients showed significantly greater percentage of IL-6 GG genotype (51.7% v 33.2%, P < .001) and G allele frequency (71.7% v 59%, P < .001) than normotensive subjects. The GG genotypic group had significantly higher plasma PAI-1 activity (16.1 +/- 9.8 v 12.3 +/- 7.5 IU/mL, P = .03) and antigen (32.4 +/- 23.2 v 23.2 +/- 13.5 ng/mL, P = .01) than the CC genotypic group, with intermediate values in the GC genotypic group (15.9 +/- 9.0 IU/mL and 29.1 +/- 17.5 ng/mL). Multiple linear regression analysis in all study subjects and in normotensive subjects documented an independent dominant effect of IL-6 G-174C gene polymorphism on plasma levels of PAI-1 activity (P = .02 and .01) and antigen (P = .02 and .03) after log transformation and adjustment for confounding factors.
  
  
  CONCLUSIONS
  The present study showed a positive association of the IL-6 GG genotype with hypertension and with elevated plasma PAI-1 level in normotensive individuals in a Chinese population in Taiwan. Our findings suggest that the IL-6 gene promoter G-174C polymorphism may affect the regulation of PAI-1 and blood pressure through an inflammatory mechanism.
authors.affiliation: Department of Internal Medicine, Buddhist Tzu-Chi General Hospital, Tzu-Chi University, Hualien, Taiwan, Republic of China. jrjeng@tzuchi.com.tw
authors.forename: Jing-Ren
authors.initials: JR
authors.lastname: Jeng
authors.forename: Ji-Hung
authors.initials: JH
authors.lastname: Wang
authors.forename: Wei-Shin
authors.initials: WS
authors.lastname: Liu
authors.forename: Shee-Ping
authors.initials: SP
authors.lastname: Chen
authors.forename: Michael Yu-Chih
authors.initials: MY
authors.lastname: Chen
authors.forename: Meng-Hsiu
authors.initials: MH
authors.lastname: Wu
authors.forename: Wen-Lin
authors.initials: WL
authors.lastname: Hsu
authors.forename: Shinn-Zong
authors.initials: SZ
authors.lastname: Lin
mesh_terms: D000328:Adult; D044466:Asian People / Q000235:genetics*; D016022:Case-Control Studies; D003596:Cytosine; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006147:Guanine; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000235:genetics*; D015850:Interleukin-6 / Q000235:genetics*; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic
chemical_list: D015850:Interleukin-6; D017395:Plasminogen Activator Inhibitor 1; D006147:Guanine; D003596:Cytosine